Aptevo TherapeuticsAPVO
13F holders, Q2 2025 (June 30)6holders
$3.05avg. 13F price*
At the end of Q2 2025, 6 institutions reported holding Aptevo Therapeutics Inc. (APVO) in their 13F filings. The largest holders were Osaic Holdings, Inc. ($10K), Tower Research Capital LLC (TRC) ($4K) and SBI Securities Co., Ltd. ($2K).
- Company
- Aptevo Therapeutics Inc.
- CUSIP
- 03835L504
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $15K |
| Exits | 0 | $0 |
Ownership 6 holders
| Osaic Holdings, Inc. | 0.00% | New | 3,250 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,192 | $4K |
| SBI Securities Co., Ltd. | 0.00% | New | 588 | $2K |
| Bank of America Corp. | 0.00% | New | 3 | $9 |
| Danske Bank A/S | 0.00% | New | 1 | $3 |
| BlackRock, Inc. | 0.00% | New | 1 | $3 |
"% of holder's portfolio" is APVO's weight in each manager's 13F, not the share of Aptevo Therapeutics Inc. the manager owns.